» Articles » PMID: 36742338

Maternal Synapsin Autoantibodies Are Associated with Neurodevelopmental Delay

Abstract

Maternal autoantibodies can be transmitted diaplacentally, with potentially deleterious effects on neurodevelopment. Synapsin 1 (SYN1) is a neuronal protein that is important for synaptic communication and neuronal plasticity. While monoallelic loss of function (LoF) variants in the gene result in X-linked intellectual disability (ID), learning disabilities, epilepsy, behavioral problems, and macrocephaly, the effect of SYN1 autoantibodies on neurodevelopment remains unclear. We recruited a clinical cohort of 208 mothers and their children with neurologic abnormalities and analyzed the role of maternal SYN1 autoantibodies. We identified seropositivity in 9.6% of mothers, and seropositivity was associated with an increased risk for ID and behavioral problems. Furthermore, children more frequently had epilepsy, macrocephaly, and developmental delay, in line with the SYN1 LoF phenotype. Whether SYN1 autoantibodies have a direct pathogenic effect on neurodevelopment or serve as biomarkers requires functional experiments.

Citing Articles

Antibodies in neurological diseases: Established, emerging, explorative.

Li L, Keles A, Homeyer M, Pruss H Immunol Rev. 2024; 328(1):283-299.

PMID: 39351782 PMC: 11659937. DOI: 10.1111/imr.13405.


Role of Maternal Immune Factors in Neuroimmunology of Brain Development.

Mohebalizadeh M, Babapour G, Maleki Aghdam M, Mohammadi T, Jafari R, Shafiei-Irannejad V Mol Neurobiol. 2023; 61(12):9993-10005.

PMID: 38057641 DOI: 10.1007/s12035-023-03749-2.


Synapsin autoantibodies during pregnancy are associated with fetal abnormalities.

Bunger I, Talucci I, Kreye J, Holtje M, Makridis K, Foverskov Rasmussen H Brain Behav Immun Health. 2023; 33:100678.

PMID: 37692096 PMC: 10483408. DOI: 10.1016/j.bbih.2023.100678.

References
1.
Maljevic S, Moller R, Reid C, Perez-Palma E, Lal D, May P . Spectrum of GABAA receptor variants in epilepsy. Curr Opin Neurol. 2019; 32(2):183-190. DOI: 10.1097/WCO.0000000000000657. View

2.
Hilfiker S, Benfenati F, Doussau F, Nairn A, Czernik A, Augustine G . Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci. 2005; 25(10):2658-69. PMC: 6725186. DOI: 10.1523/JNEUROSCI.4278-04.2005. View

3.
Han V, Patel S, Jones H, Dale R . Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol. 2021; 17(9):564-579. DOI: 10.1038/s41582-021-00530-8. View

4.
Pruss H . Autoantibodies in neurological disease. Nat Rev Immunol. 2021; 21(12):798-813. PMC: 8111372. DOI: 10.1038/s41577-021-00543-w. View

5.
Giannandrea M, Guarnieri F, Gehring N, Monzani E, Benfenati F, Kulozik A . Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356× mutation in synapsin I. PLoS One. 2013; 8(6):e67724. PMC: 3688603. DOI: 10.1371/journal.pone.0067724. View